资源类型:
期刊/会议
收录情况:
◇ SCIE
◇ CPCI(ISTP)
文章类型:
会议摘要
作者:
Wei, Lai[1]
*
;
Xie, Qing[2]
;
Hou, Jinlin[3]
;
Tang, Hong[4]
;
Ning, Qin[5]
;
Cheng, Jun[6]
;
Nan, Yuemin[7]
;
Zhang, Lunli[8]
;
Li, Jun[9]
;
Jiang, Jianning[10]
;
McNabb, Brian L.[11]
;
Zhang, Fangqiu[12]
;
Camus, Gregory[13]
;
Mo, Hongmei[13]
;
McNally, John[11]
;
Brainard, Diana M.[11]
;
Subramanian, Mani[11]
;
Gong, Guozhong[14]
;
Mou, Zhuangbo[15]
;
Wu, Shanming[16]
;
Wang, Qui-Qiang[17]
;
Hu, Peng[18]
;
Gao, Yanhang[19]
;
Jia, Jidong[20]
;
Duan, Zhongping[21]
;
单位:
[1]Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2]Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China
[3]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[4]Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
四川大学华西医院
[5]Huanzhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
华中科技大学同济医学院附属同济医院
[6]Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[7]Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China
[8]Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[9]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
江苏省人民医院
[10]Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
[11]Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA
[12]Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA
[13]Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA
[14]Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[15]Jinan Infect Dis Hosp, Jinan, Shandong, Peoples R China
[16]Clin Ctr Shanghai Publ Hlth, Shanghai, Peoples R China
[17]Peking Univ, Hosp 1, Beijing, Peoples R China
[18]Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
[19]Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
[20]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
首都医科大学附属北京友谊医院
[21]Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
出处:
HEPATOLOGY.2017,66:642A-642A.
ISSN:
0270-9139
基金:
AbbvieAbbott Laboratories; BMSBristol-Myers Squibb; RocheRoche Holding; NovartisNovartis; GSKGlaxoSmithKline; JJ
WOS:
WOS:000412089801332
中科院(CAS)分区:
出版当年[2016]版:
大类
|
1 区
医学
小类
|
1 区
胃肠肝病学
最新[2025]版:
大类
|
1 区
医学
小类
|
1 区
胃肠肝病学
JCR分区:
出版当年[2015]版:
Q1
GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版:
Q1
GASTROENTEROLOGY & HEPATOLOGY
影响因子:
13
最新[2023版]
15.5
最新五年平均
11.711
出版当年[2015版]
11.854
出版当年五年平均
11.055
出版前一年[2014版]
13.246
出版后一年[2016版]
第一作者:
Wei, Lai
第一作者单位:
[1]Peking Univ, Peoples Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Wei Lai,Xie Qing,Hou Jinlin,et al.Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial[J].HEPATOLOGY.2017,66:642A-642A.
APA:
Wei, Lai,Xie, Qing,Hou, Jinlin,Tang, Hong,Ning, Qin...&Duan, Zhongping.(2017).Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial.HEPATOLOGY,66,
MLA:
Wei, Lai,et al."Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial".HEPATOLOGY 66.(2017):642A-642A